Stereotaxis (STXS) Cash from Operations Growth (5y) (2015 - 2026)
Stereotaxis (STXS) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.02 Bn | 121.80 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.84 Bn | 44.03 Bn | 2.15 Bn |
| 3 | Alcon | 33.09 Bn | 31.43 Bn | 1.53 Bn |
| 4 | Medline | 32.94 Bn | 30.70 Bn | 1.84 Bn |
| 5 | Resmed | 29.41 Bn | 27.75 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.25 Bn | 22.82 Bn | 329.20 Mn |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn |
| 10 | Stereotaxis | 132.02 Mn | 117.40 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.37% |
| Dec 31, 2025 | -71.62% |
| Sep 30, 2025 | -54.15% |
| Jun 30, 2025 | -26.10% |
| Mar 31, 2025 | 3.86% |
| Dec 31, 2024 | 21.62% |
| Sep 30, 2024 | -60.55% |
| Jun 30, 2024 | -42.86% |
| Mar 31, 2024 | -5.71% |
| Dec 31, 2023 | -25.70% |
| Sep 30, 2023 | -32.33% |
| Jun 30, 2023 | -51.49% |
| Mar 31, 2023 | -6.75% |
| Dec 31, 2022 | -26.03% |
| Sep 30, 2022 | -38.82% |
| Jun 30, 2022 | -9.78% |
| Mar 31, 2022 | 3.84% |
| Dec 31, 2021 | -56.06% |
| Sep 30, 2021 | 4.39% |
| Jun 30, 2021 | 15.39% |